295 First-in-human Phase I trial of IBI188, an anti-CD47 targeting monoclonal antibody, in patients with advanced solid tumors and lymphomas

by Hui Zhou, Ying Liu, Fang Liu, Siqing Fu, Nehal Lakhani, Marlana Orloff, Kedan Lin, Shuling Yan
Published 2020-11-01